News • New treatment approach
'Self-destructing' parasite: The solution for drug-resistant malaria?
Over the last 50 years, malaria parasites have developed resistance to seven drugs, but a new way to identify future antimalarials holds promise.
Infections
News • Surface treatment
Preventing deadly hospital infections without antibiotics
Hospital-acquired infections are dangerous for patients and costly for clinics. A novel surface treatment could help improve the safety of medical devices and ease the economic burden.
News • Protein malformation
Covid-19: immune reaction may cause amyloid generation
In patients with serious and long-term Covid-19, disturbed blood coagulation is often observed. Now, Swedish researchers found a connection between harmful amyloid production and Covid-19 symptoms.
News • To enter human cells
SARS-CoV-2 hijacks antiviral human proteins
SARS-CoV-2 depends on the broadly antiviral interferon-induced human transmembrane proteins , to enter human cells and replicate inside them.
News • After hospitalization
Covid: two years later, half of patients still have symptoms
Two years after infection with COVID-19, half of patients who were admitted to hospitals still have at least one symptom, according to the longest follow-up study to date.
News • HHV awaken via microRNA
Why herpes keeps coming back
Dormant herpesviruses induce their reactivation via a previously unknown cellular mechanism mediated by a viral microRNA, Würzburg researchers discovered.
News • Coronavirus census
WHO: Covid-19 pandemic claimed almost 15 million lives
In 2020 and 2021, the death toll associated with Covid-19 was approximately 14.9 million, according to the World Health Organization. However, the global distribution has been far from equal.
News • Cognitive impairment after infection
Severe Covid-19 can 'age' our brain by 20 years, study finds
Cognitive impairment as a result of severe Covid-19 is similar to that sustained between 50 and 70 years of age and is the equivalent to losing 10 IQ points, scientists found.
News • Viral aftereffects
Long Covid: Six in ten have at least one symptom one year after infection
Six in ten people with Covid-19 still have at least one symptom a year later, a new study has found. Furthermore, symptoms that don’t clear up after 15 weeks are likely to last at least a year.
Article • UHPLC-MS/MS analysis
Predicting Covid-19 infection severity with mass spec
Using mass spectrometry and chromatography techniques, UK researchers have developed an approach to predict infection severity among Covid-19 patients, as well as potential outcomes.
News • Global study finds increase in deaths
Why is Covid-19 more deadly on weekends?
A global analysis of nearly 6 million Covid-19 deaths finds an increase in mortality at weekends compared to weekdays. Bureaucratic and reporting delays alone do not explain this, researchers report.
News • Multiplex immunoassay
Dengue Fever: hope for low-cost diagnostics
Accurate home testing could be used for a wider range of illnesses, as new research shows the capability of smartphone-powered tests for Dengue Fever.
News • Identifying antimicrobials
Automated CAST-R system helps to fight blood infections
When treating acute infections, health care providers must quickly identify the best antibiotics for fighting the infection. An automated system provides swift, accurate results for determining the best antibiotics at the right dose.
News • Effective prevention
Covid-19 vaccination greatly reduces infectious viral load
By comparing the infectious viral load caused by ancestral SARS-CoV-2 as well as by the Delta and Omicron variants, scientists highlight the benefits of vaccination.
News • Aspergillosis monitoring
Chip-based model to observe fungal spread in the lung
A chip-based infection model developed by Jena researchers enables live microscopic observation of damage to lung tissue caused by the invasive fungal infection aspergillosis.
News • Covid-19 drug monitoring
Smart sensor to evaluate vaccine safety
A new study enables developers to determine vaccine safety via smart sensors that measure objective physiological parameters. This could end the reliance on subjective reports of study participants.
News • Highly accurate
A 30-second coronavirus test
The COVID-19 testing device can detect coronavirus infection in as little as 30 seconds as sensitively and accurately as a PCR test.
News • Mini-livers on a chip
Organoids: step towards hepatitis C vaccine
A platform for studying how the human immune system responds to hepatitis C infection by combining microfluidic technology with liver organoids could speed the hunt for a vaccine.
News • 3D printed masks
Animal noses inspire new air filter designs
The new 3D-printable mask design promises easy breathing for users while maintaining similar levels of protection against pathogens found in N95 and surgical masks.
News • Deep learning diagnoses
AI detects COVID-19 from smartwatch sensors
Combining questions about a person's health with data from smartwatch sensors, a new app can predict within minutes whether someone is infected with COVID-19.
News • In 2020
COVID-19 restrictions linked to 750,000 fewer dengue cases
COVID-19 measures such as school closures and ‘high-traffic and mixing’ areas had the strongest association, providing clues for new intervention approaches.
News • Bacterial protection strategy
Protective 'chain mail' of C.difficile revealed
A newly discovered structure of chain-mail may explain the success of C.difficile at defending itself against antibiotics and immune system molecules.
News • Adaptable for screening
An optical methodology for rapid detection of COVID-19
The tool has made it possible to detect SARS-CoV-2 in exudate from symptomatic patients with a sensitivity of 100% and a specificity of 87.5%
News • New bone implants
Superhero substance used to combat infection
A new kind of bone implant reduces the chance of infection, and therefore significantly decreases implant failure rates.
News • Prevention through infection
Vaccine against liver cancer and fibrosis shows promise
A new study offers hope against liver cancer: A vaccine proved to be safe and effective protection in premalignant and malignant liver diseases in preclinical mouse models.